Aldose reductase mediates the mitogenic signals of cytokines (Q44326992)

2 December 2017

Aldose reductase mediates the mitogenic signals of cytokines (English)

1 reference

2 December 2017

1

1 reference

2 December 2017

Deepak Chandra

2

1 reference

2 December 2017

Sanjay Srivastava

series ordinal

3

1 reference

2 December 2017

Aruni Bhatnagar

series ordinal

4

1 reference

2 December 2017

Satish K Srivastava

series ordinal

5

1 reference

2 December 2017

1 February 2003

1 reference

Chemico-biological Interactions

2 December 2017

1 reference

2 December 2017

143-144

1 reference

2 December 2017

587-596

1 reference

Glycoxidation and lipoxidation in atherogenesis

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Lipid and lipoprotein modification by advanced glycosylation end-products: role in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Involvement of aldose reductase in the metabolism of atherogenic aldehydes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Structural and kinetic determinants of aldehyde reduction by aldose reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Selective recognition of glutathiolated aldehydes by aldose reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary artery smooth muscle cells induced by high glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Oxidative stress as a regulator of gene expression in the vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

NF-kappa B activation by tumor necrosis factor and interleukin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Tumor necrosis factor receptor levels are associated with carotid atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Increased synthesis of tumor necrosis factor-alpha in uterine explants from pregnant diabetic rats and in primary cultures of uterine cells in high glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Assay for redox-sensitive transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Antioxidants, NFkappaB activation, and diabetogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

Antioxidants differentially regulate activation of nuclear factor-kappa B, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

N-acetylcysteine attenuates TNF-alpha-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900194-1

10.1016/S0009-2797(02)00194-1

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference